Latest quarter, TTM, and growth are now pre-computed for chat and templates.
Quarterly coverage: 47 periods · latest quarter FY2025-Q3 · TTM revenue growth -6.3%.
Standardized 17-year financial series for WESTLAKE CORP, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.
Quarterly coverage: 47 periods · latest quarter FY2025-Q3 · TTM revenue growth -6.3%.
The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.
| Fiscal year | Revenue | Adj. EBITDA | EBIT | Net result | Op. cash flow | Capex | Net debt | Status |
|---|---|---|---|---|---|---|---|---|
| FY2009 | 2B | — | 107M | 53M | 236M | -100M | — | comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing inventory · missing net financial debt · missing research and development · missing total assets |
| FY2010 | 3B | — | 378M | 221M | 283M | -81M | 134M | comparative annual fact carried from later 10k · missing adjusted ebitda · missing research and development |
| FY2011 | 4B | — | 447M | 259M | 362M | -177M | -61M | missing adjusted ebitda · missing research and development |
| FY2012 | 4B | — | 615M | 386M | 624M | -387M | -26M | missing adjusted ebitda · missing research and development |
| FY2013 | 322M | — | 953M | 610M | 753M | -679M | 303M | missing adjusted ebitda · missing research and development |
| FY2014 | 148M | — | 1B | 679M | 1B | -431M | -117M | missing adjusted ebitda · missing research and development |
| FY2015 | 108M | — | 960M | 646M | 1B | -491M | 102M | missing adjusted ebitda · missing research and development |
| FY2016 | 191M | — | 581M | 399M | 834M | -628M | 3B | missing adjusted ebitda · missing research and development |
| FY2017 | 8B | — | 1B | 1B | 2B | -577M | 2B | missing adjusted ebitda · missing research and development |
| FY2018 |
SEC EDGAR companyfacts · XBRL · consolidated_reported
comparative_annual_fact_carried_from_later_10k · missing_accounts_receivable · missing_adjusted_ebitda · missing_current_assets · missing_current_liabilities · missing_inventory · missing_net_financial_debt · missing_research_and_development · missing_total_assets
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
comparative_annual_fact_carried_from_later_10k · missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filing| 9B |
| — |
| 1B |
| 996M |
| 1B |
| -702M |
| 2B |
| missing adjusted ebitda · missing research and development |
| FY2019 | 8B | — | 656M | 421M | 1B | -787M | 3B | missing adjusted ebitda · missing research and development |
| FY2020 | 8B | — | 429M | 330M | 1B | -525M | 2B | missing adjusted ebitda · missing research and development |
| FY2021 | 12B | — | 3B | 2B | 2B | -658M | 3B | missing adjusted ebitda · missing research and development |
| FY2022 | 16B | — | 3B | 2B | 3B | -1B | 3B | missing adjusted ebitda · missing research and development |
| FY2023 | 13B | — | 729M | 479M | 2B | -1B | 2B | missing adjusted ebitda · missing research and development |
| FY2024 | 12B | — | 875M | 602M | 1B | -1B | 2B | missing adjusted ebitda · missing interest expense · missing research and development |
| FY2025 | 11B | — | -2B | -2B | 465M | -995M | 3B | missing adjusted ebitda · missing interest expense · missing research and development |
SEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
SEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_interest_expense · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_interest_expense · missing_research_and_development
Open official source filing